← Back to dashboard
Intuitive Surgical
Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
Metric timing
This page mixes live market data, trailing fundamentals, and latest reported statement data.
Live / market snapshot
Price, 1D change, market cap, and enterprise value are current market-based figures.
TTM / forward
Most valuation and margin cards are trailing twelve months, while forward P/E uses forward consensus.
Latest quarter / dividend cadence
Balance-sheet ratios use the latest reported quarter. Dividend cadence is inferred from recent payout history.
latest annual revenue
latest quarterly revenue
latest annual profit
latest quarterly profit
annualized per share
latest ex-dividend cash amount
Latest headlines
Recent company headlines. Each link opens the original article in a new tab.
Jim Cramer on Globus Medical: “There Is Not a Lot of Money to Be Made in This One”
Globus Medical, Inc. (NYSE:GMED) was among the stocks Jim Cramer looked at as he explained the need for a tame bond market for the stock market to go higher. A caller asked for Cramer’s thoughts on the company, and he remarked: Okay, this group in particular, the medical device group, is hated in this market. […]
Is BSX Stock A Value Trap Or A Rebound Play?Boston Scientific (BSX) stock declined 47% over the last 12 months to trade near $57. Despite total revenues growing 17.4% to $20.6 billion and net income margins improving to 17.3%, the P/E multiple contracted by 70%. The selloff was triggered by a Q4 2025 GAAP EPS miss and a significant full-year 2026 organic growth guidance cut. The company's management lowered the target from a 10 to 11% range down to 6.5 to 8.0%, attributing the reset to greater-than-expected market share loss in the Electr
Forget Tesla. The Robotics Company Actually Shipping Revenue Has a $22 Billion Backlog and Nobody Is Talking About ItEveryone is still glued to Tesla (NASDAQ:TSLA) because a Q1 earnings beat, the robotaxi pitch, and the Optimus humanoid tease have convinced retail traders the autonomy story finally pays off this year. The Tesla Trade Is Crowded and Priced for a Miracle Tesla carries a P/E of 406 and a free cash flow yield of ... Forget Tesla. The Robotics Company Actually Shipping Revenue Has a $22 Billion Backlog and Nobody Is Talking About It
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to KnowIntuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Assessing Intuitive Surgical (ISRG) Valuation After The Recent Share Price PullbackRecent performance context for Intuitive Surgical Intuitive Surgical (ISRG) has been under pressure recently, with the stock down about 10% over the past month and about 15% over the past 3 months. This has prompted investors to reassess expectations. See our latest analysis for Intuitive Surgical. Beyond the recent pullback, the stock has also declined about 25% based on the year to date share price return, even though the 3 year and 5 year total shareholder returns remain positive. If you...
Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays of the Healthcare BoomSurgical robotics is quietly becoming an artificial intelligence story. Every robotic procedure generates structured video, kinematic, and outcomes data that platforms feed back into surgeon training, intraoperative guidance, and predictive analytics. That flywheel is the moat. The three companies owning the installed bases to build it are Intuitive Surgical (NASDAQ: ISRG), Medtronic (NYSE: MDT), and ... Surgical Robotics Meets AI: Intuitive Surgical, Medtronic, and Stryker Are the Sleeper Plays
Why it could benefit going forward
- Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
- Its installed base, procedure growth, and recurring instruments model create a stronger moat than most robotics names.
- This adds a high-quality medical robotics angle that is less tied to data-center spending or industrial cycles.
Moat / edge
- Large installed base and deep surgeon training ecosystem.
- Recurring revenue from instruments, accessories, and service.
- Years of lead time and brand strength in robotic-assisted surgery.
What to watch
- Procedure growth and system placements.
- Adoption of newer da Vinci platforms and adjacent products.
- Gross-margin resilience as the business scales.
Key risks
- Premium valuation can leave less room for execution misses.
- Hospital capital-spending cycles still matter.
Business snapshot
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.